Bio Cryst Pharmaceuticals Appoints Babar Ghias As Chief Financial Officer

Jul 07, 2025•11 days ago

Position

Chief Financial Officer

Company

BioCryst Pharmaceuticals

Babar Ghias

DurhamTherapeuticsBiotechnologyHealth Care

Description

BioCryst Pharmaceuticals announced the appointment of Babar Ghias as the new Chief Financial Officer (CFO) and head of corporate development. Ghias brings extensive experience in financial leadership and operational expertise to the company.

Company Information

Company

BioCryst Pharmaceuticals

Location

Durham, North Carolina, United States

About

BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Donald hidden

hidden

Babar hidden